Literature DB >> 26518188

Sleep apnea syndrome in acromegalic patients: Can morphological evaluation guide us to optimize treatment?

Ana M Ramos-Levi1, Mónica Marazuela2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26518188     DOI: 10.1007/s12020-015-0787-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

Review 1.  Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.

Authors:  George Tolis; Nicholas G Angelopoulos; Eugenia Katounda; Grigorios Rombopoulos; Victoria Kaltzidou; Dimitrios Kaltsas; Anthi Protonotariou; Aristides Lytras
Journal:  Neuroendocrinology       Date:  2006-10-13       Impact factor: 4.914

2.  Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients.

Authors:  Cinzia Castellani; Giuseppe Francia; Luca Dalle Carbonare; Marcello Ferrari; Elena Viva; Roberto Cerini; Alessandro Zaccarella; Lorenzo Trevisiol; Maria Vittoria Davi'
Journal:  Endocrine       Date:  2015-06-21       Impact factor: 3.633

3.  Effect of transsphenoidal surgery on sleep apnoea in acromegaly.

Authors:  Lisa Sze; Christoph Schmid; Konrad E Bloch; René Bernays; Michael Brändle
Journal:  Eur J Endocrinol       Date:  2007-03       Impact factor: 6.664

4.  Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity.

Authors:  M S Ip; K C Tan; W C Peh; K S Lam
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

5.  Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly.

Authors:  S Dostalova; K Sonka; Z Smahel; V Weiss; J Marek; D Horinek
Journal:  Eur J Endocrinol       Date:  2001-05       Impact factor: 6.664

6.  Sleep apnea in acromegaly.

Authors:  R R Grunstein; K Y Ho; C E Sullivan
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

7.  Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.

Authors:  Maria Vittoria Davi'; Luca Dalle Carbonare; Andrea Giustina; Marcello Ferrari; Anna Frigo; Vincenzo Lo Cascio; Giuseppe Francia
Journal:  Eur J Endocrinol       Date:  2008-09-02       Impact factor: 6.664

Review 8.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

Authors:  Annamaria Colao; Diego Ferone; Paolo Marzullo; Gaetano Lombardi
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

Review 9.  Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly.

Authors:  L M Fatti; M Scacchi; A I Pincelli; E Lavezzi; F Cavagnini
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

10.  A consensus on the diagnosis and treatment of acromegaly complications.

Authors:  S Melmed; F F Casanueva; A Klibanski; M D Bronstein; P Chanson; S W Lamberts; C J Strasburger; J A H Wass; A Giustina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

  10 in total
  4 in total

Review 1.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

Review 2.  Insulin Resistance in Patients With Acromegaly.

Authors:  Greisa Vila; Jens Otto L Jørgensen; Anton Luger; Günter K Stalla
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-30       Impact factor: 5.555

3.  Evaluation of Acromegaly patients with sleep disturbance related symptoms.

Authors:  Deniz Celik; Sezgi Sahin Duyar; Funda Aksu; Selma Firat; Bulent Ciftci
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 2.340

4.  Evaluation of the pharyngeal airway using computational fluid dynamics in patients with acromegaly.

Authors:  Keika Mukaihara; Maiko Hasegawa-Moriyama; Tomonori Iwasaki; Youichi Yamasaki; Yuichi Kanmura
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.